Date published: 2026-4-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

DLK2 Inhibitors

DLK2 inhibitors constitute a class of chemical compounds that have garnered attention within the realm of molecular biology and pharmacology due to their potential significance in regulating cellular processes. DLK2, or Dual Leucine Zipper Kinase 2, is a protein kinase with multifaceted functions in cellular signaling and pathways. One of its primary roles is to phosphorylate specific substrates, thereby modulating various intracellular processes. DLK2 inhibitors are designed to interact with the active site or binding pocket of DLK2, effectively hindering its catalytic activity and altering its ability to phosphorylate target proteins. This inhibition has far-reaching implications for intracellular signaling cascades and cellular response to external stimuli.

Structurally, DLK2 inhibitors are tailored to bind to DLK2's active site with a high degree of specificity, ensuring that they exert their inhibitory effects selectively on this kinase. By perturbing DLK2's enzymatic function, these inhibitors disrupt downstream signaling pathways that depend on DLK2-mediated phosphorylation events. Consequently, they may influence cellular processes like cell growth, differentiation, and stress responses. The study of DLK2 inhibitors is of substantial interest to researchers, as it provides a deeper understanding of the regulatory mechanisms governing vital cellular functions. This knowledge serves to advance our comprehension of basic cell biology, and while it has potential applications in diverse research domains, further investigation is necessary to elucidate the full scope of their utility.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Through its impact on Wnt signaling and GSK-3 inhibition, it might indirectly affect DLK2 expression.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Inhibits the Hedgehog signaling pathway, which might have a downstream effect on DLK2 expression.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

A gamma-secretase inhibitor, potentially affecting Notch signaling and indirectly DLK2 expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, potentially impacting signaling pathways that regulate DLK2 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR pathway, which could affect protein synthesis and potentially DLK2 expression.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

Wnt pathway inhibitor, potentially impacting signaling pathways that regulate DLK2 expression.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$107.00
$156.00
4
(1)

TGF-beta receptor kinase inhibitor, could influence DLK2 expression through TGF-beta signaling.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, could alter gene expression patterns including DLK2 expression.